Cassava Sciences, Inc.
SAVA
$1.57
-$0.09-5.42%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.34M | -17.66M | -15.37M | -47.90M | -97.22M |
| Total Depreciation and Amortization | 1.13M | 1.23M | 1.36M | 1.45M | 1.53M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.89M | -95.51M | -100.17M | -36.79M | 4.59M |
| Change in Net Operating Assets | -1.83M | 33.96M | 27.96M | -4.65M | 9.08M |
| Cash from Operations | -116.93M | -77.98M | -86.21M | -87.90M | -82.03M |
| Capital Expenditure | -103.00K | -87.00K | -92.00K | -57.00K | -414.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -103.00K | -87.00K | -92.00K | -57.00K | -414.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 124.47M | 124.70M | 125.16M | 24.66M | 2.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 124.47M | 124.70M | 125.16M | 24.66M | 2.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.44M | 46.63M | 38.85M | -63.30M | -79.88M |